Arrhythmic risk stratification in patients with left ventricular ring-like scar.

arrhythmias cardiac magnetic resonance cardiomyopathy electrocardiogram prognosis ring-like scar risk stratification

Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
01 Nov 2024
Historique:
received: 29 05 2024
revised: 28 07 2024
accepted: 30 10 2024
medline: 1 11 2024
pubmed: 1 11 2024
entrez: 1 11 2024
Statut: aheadofprint

Résumé

Left ventricular (LV) ring-like scar on cardiac magnetic resonance (CMR) has been linked to malignant arrhythmias in patients with non-ischemic cardiomyopathy. This study aimed to perform a comprehensive evaluation of this phenotype and to identify risk factors for life-threatening arrhythmic events (LAEs), a composite of sudden cardiac death (SCD), aborted SCD, and sustained ventricular tachycardia. One-hundred-fifteen patients (median age 39 [IQR 28-52], 42% females) were identified at 6 referral centres. Inclusion criteria were ring-like LV scar (≥ 3 contiguous segments with subepicardial/midwall late gadolinium enhancement (LGE) in the same slice) and one among: pathogenic/likely pathogenic genetic variant, family history for cardiomyopathy, or arrhythmogenic cardiomyopathy diagnosis. During the study follow-up, survival-free from LAEs was 60% (3.8 events/100 patients/year); at a median follow-up of 4.6 years (IQR 1.7-8.4) it was 84%. On multivariable analysis, anterior Q waves (HR:1.030, 95% CI:1.014-1.046, p < 0.001), QRS width (HR:4.642, 95% CI:1.296-16.628, p=0.018), and LV end-diastolic volume index (LVEDVi) (HR:1.011, 95% CI:1.001-1.021, per mL/m2 increase, p=0.040) were independently associated with LAEs; with good discrimination power (Harrell's C-index=0.796). Three risk categories were identified: normal ECG, abnormal ECG and no LAEs predictive variables, abnormal ECG and ≥ 1 LAEs predictive variables, with a decreasing survival from 100% to 65% and 49%, respectively (Log-rank test = 0.015). In this study, the LV ring-like scar phenotype was associated with a high rate of malignant arrhythmias in presence of anterior Q waves, QRS prolongation, and increased LVEDVi. A normal ECG identified a lower risk subgroup. Left ventricular (LV) ring-like scar represents the cardiac magnetic resonance (CMR) expression of different genetic substrates and several clinical scenarios. Arrhythmic risk stratification predictors are still not well understood. In this study: LV ring-like scar exhibits a high rate of ventricular arrhythmias, particularly in the presence of ECG abnormalities (anterior Q waves and QRS enlargement) together with increased LV volumes Other commonly used risk predictors (such as LV systolic function) did not add significant prognostic information.

Autres résumés

Type: plain-language-summary (eng)
Left ventricular (LV) ring-like scar represents the cardiac magnetic resonance (CMR) expression of different genetic substrates and several clinical scenarios. Arrhythmic risk stratification predictors are still not well understood. In this study: LV ring-like scar exhibits a high rate of ventricular arrhythmias, particularly in the presence of ECG abnormalities (anterior Q waves and QRS enlargement) together with increased LV volumes Other commonly used risk predictors (such as LV systolic function) did not add significant prognostic information.

Identifiants

pubmed: 39486037
pii: 7863405
doi: 10.1093/eurjpc/zwae353
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.

Auteurs

Vanda Parisi (V)

Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart.

Maddalena Graziosi (M)

Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart.

Luis R Lopes (LR)

Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Institute of Cardiovascular Science, University College London, London, UK.

Antonio De Luca (A)

Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina and University of Trieste, Trieste, Italy.

Ferdinando Pasquale (F)

Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart.

Giacomo Tini (G)

Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University, Rome, Italy.

Mattia Targetti (M)

Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy.

Maria R Cueto (MR)

Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Heart Failure and Cardiomyopathies Clinic, Germans Trias i Pujol University Hospital, Badalona, Spain.

Ana R Moura (AR)

Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Unidade Local de Saúde de Matosinhos, Portugal.

Raffaello Ditaranto (R)

Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart.

Camilla Torlasco (C)

IRCCS, Istituto Auxologico Italiano, Department of Cardiology, Cardiomyopathy Unit, San Luca Hospital, Milan, Italy.

Nevio Taglieri (N)

Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart.

Elena Nardi (E)

Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.

Luigi Lovato (L)

Pediatric and Adult Cardio-Thoracic and Vascular, Onco-Hematologic and Emergency Radiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna.

João B Augusto (JB)

Institute of Cardiovascular Science, University College London, London, UK.
Cardiology Department, Hospital Prof Doutor Fernando Fonseca, Amadora, Portugal.
Católica Medical School, Universidade Católica Portuguesa, Lisbon, Portugal.

Nazzareno Galiè (N)

Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart.

Lia Crotti (L)

European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart.
IRCCS, Istituto Auxologico Italiano, Department of Cardiology, Cardiomyopathy Unit, San Luca Hospital, Milan, Italy.
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Alessio Gasperetti (A)

Division of Cardiology, School of Medicine, Johns Hopkins University, 600 N. Wolfe St. Blalock 545, Baltimore, MD 21287, USA.

Mauro Biffi (M)

Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart.

Camillo Autore (C)

Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University, Rome, Italy.

Marco Merlo (M)

Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina and University of Trieste, Trieste, Italy.

Iacopo Olivotto (I)

Meyer Children Hospital and Careggi University Hospital, University of Florence, Florence, Italy.

Gianfranco Sinagra (G)

Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina and University of Trieste, Trieste, Italy.

Perry M Elliott (PM)

Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Institute of Cardiovascular Science, University College London, London, UK.

Elena Biagini (E)

Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart.

Classifications MeSH